Free Trial

United Therapeutics (UTHR) SEC Filings & 10K Form

United Therapeutics logo
$306.97 -1.05 (-0.34%)
Closing price 03/28/2025 04:00 PM Eastern
Extended Trading
$309.06 +2.09 (+0.68%)
As of 03/28/2025 07:16 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent United Therapeutics SEC Filings

DateFilerForm TypeView
03/25/2025
3:31 PM
Thompson Tommy G (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
3:47 PM
Thompson Tommy G (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2025
5:11 PM
PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
3:11 PM
PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/11/2025
3:30 PM
BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
3:31 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:33 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
3:41 PM
BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
3:31 PM
KURZWEIL RAY (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
3:34 PM
Thompson Tommy G (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2025
5:33 AM
United Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/26/2025
5:35 AM
United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/25/2025
3:30 PM
BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
3:30 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
3:30 PM
BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
3:32 PM
BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
9:25 AM
United Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SCHEDULE 13G/A
02/05/2025
6:10 AM
STATE STREET CORP (Filed by)
United Therapeutics (Subject)
Form SCHEDULE 13G
01/22/2025
3:30 PM
BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
3:31 PM
BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
3:30 PM
BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
3:30 PM
PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
7:57 AM
United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
3:29 PM
PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/07/2025
3:30 PM
BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:31 PM
Mesa Nilda (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:32 PM
BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
3:08 PM
Mesa Nilda (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/26/2024
3:30 PM
BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
3:31 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
4:51 PM
SULLIVAN LOUIS W (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/17/2024
3:31 PM
BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:38 PM
BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/10/2024
3:32 PM
BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
3:30 PM
BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
5:44 AM
BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
4:37 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2024
4:04 PM
BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/12/2024
10:32 AM
Olian Judy D. (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/08/2024
3:17 PM
Mesa Nilda (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/06/2024
4:07 PM
BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Musk’s real agenda in D.C. (Ad)

In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of America…

11/05/2024
3:30 PM
EDGEMOND JAMES (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
3:33 PM
Giltner Richard (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/01/2024
3:45 PM
CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/01/2024
3:23 PM
BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/30/2024
5:32 AM
United Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/30/2024
5:34 AM
United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2024
3:30 PM
EDGEMOND JAMES (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2024
3:13 PM
EDGEMOND JAMES (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/22/2024
3:30 PM
EDGEMOND JAMES (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2024
4:19 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2024
12:03 PM
STATE STREET CORP (Filed by)
United Therapeutics (Subject)
Form SC 13G
10/15/2024
3:30 PM
EDGEMOND JAMES (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
7:19 AM
EDGEMOND JAMES (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/08/2024
3:30 PM
EDGEMOND JAMES (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/24/2024
3:30 PM
EDGEMOND JAMES (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2024
3:30 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
3:30 PM
EDGEMOND JAMES (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
3:30 PM
Olian Judy D. (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
3:20 PM
EDGEMOND JAMES (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/10/2024
3:30 PM
EDGEMOND JAMES (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
3:30 PM
PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
3:34 PM
EDGEMOND JAMES (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
3:35 PM
PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/03/2024
3:18 PM
EDGEMOND JAMES (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/28/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2024
3:30 PM
EDGEMOND JAMES (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2024
3:24 PM
EDGEMOND JAMES (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/22/2024
3:30 PM
CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:30 PM
EDGEMOND JAMES (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
3:30 PM
BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
4:16 PM
BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2024
4:17 PM
BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
9:54 AM
United Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/31/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
5:31 AM
United Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/31/2024
5:33 AM
United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/29/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
3:30 PM
DWEK RAYMOND (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
3:30 PM
KURZWEIL RAY (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
3:30 PM
MALCOLM JAN (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
3:30 PM
Mesa Nilda (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
3:30 PM
PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
3:30 PM
MAXWELL LINDA (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
3:30 PM
SULLIVAN LOUIS W (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Musk’s real agenda in D.C. (Ad)

In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of America…

07/26/2024
3:30 PM
Thompson Tommy G (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
3:30 PM
CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
3:30 PM
Giltner Richard (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
3:30 PM
Olian Judy D. (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2024
3:30 PM
Giltner Richard (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:UTHR) was last updated on 3/31/2025 by MarketBeat.com Staff
From Our Partners